Logo do repositório
 
Publicação

Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity

datacite.subject.fosCiências Médicas
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorAlmeida, Ana C.
dc.contributor.authorSilva, Gabriela A.
dc.contributor.authorSantini, Gabriele
dc.contributor.authorBrízido, Margarida
dc.contributor.authorCorreia, Miguel
dc.contributor.authorCoelho, Constança
dc.contributor.authorBorrego, Luís Miguel
dc.date.accessioned2025-09-16T13:51:56Z
dc.date.available2025-09-16T13:51:56Z
dc.date.issued2021-11
dc.description.abstractTo determine the association between hyperglycemia, glycated albumin (GlyA) and retinopathy of prematurity (ROP). Prospective study of all infants under ROP screening from March 2017 to July 2019. All demographic, clinical and laboratory data were collected. Glucose was measured at birth and every 8 h for the first week and serum GlyA was evaluated at birth, 1st, 2nd and 4th weeks after birth. Reference range for GlyA was obtained. Univariate logistic regression was used to examine risk factors for ROP followed by multivariate regression. A total of 152 infants were included in the study. Median gestational age was 30 weeks and median birth weight 1240 g. Thirty-three infants (21.7%) had ROP. Hyperglycemia was present in 24 (72.7%) infants diagnosed with any ROP versus 6 (0.05%) in those without ROP. Median GlyA at birth, 1st, 2nd and 4th and respective reference ranges were 8.50% (6.00–12.65), 8.20% (5.32–11.67), 8.00% (5.32–10.00) and 7.90% (5.30–9.00) respectively. After multivariate logistic regression, hyperglycemia but not GlyA, remained a significant risk factor for ROP overpowering the other recognized risk factors (Exp (B) 28.062, 95% CI for Exp(B) 7.881–99.924 p < 0.001). In our cohort, hyperglycemia but not GlyA, remained a significant risk factor for ROP overpowering the other recognized risk factors.eng
dc.identifier.citationAlmeida, A.C., Silva, G.A., Santini, G. et al. Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity. Sci Rep 11, 22321 (2021). https://doi.org/10.1038/s41598-021-01861-8
dc.identifier.doi10.1038/s41598-021-01861-8
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/10400.26/58680
dc.language.isoeng
dc.peerreviewedyes
dc.publisherSpringer Nature
dc.relation.hasversionhttps://doi.org/10.1038/s41598-021-01861-8
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjecthyperglycemia
dc.subjectalbumin
dc.subjectretinopathy
dc.subjectprematurity
dc.titleCorrelation between hyperglycemia and glycated albumin with retinopathy of prematurityeng
dc.typecontribution to journal
dspace.entity.typePublication
oaire.citation.startPage22321
oaire.citation.titleScientific Reports
oaire.citation.volume11
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo_MiguelCorreia_2021_01.pdf
Tamanho:
840.7 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: